ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $652,000 | -32.1% | 1,779,024 | +1.9% | 0.00% | – |
| Q1 2019 | $960,000 | +489.0% | 1,745,322 | +430.3% | 0.00% | – |
| Q4 2018 | $163,000 | -70.4% | 329,124 | -51.5% | 0.00% | – |
| Q3 2018 | $551,000 | -9.7% | 678,241 | +1.2% | 0.00% | – |
| Q2 2018 | $610,000 | -65.6% | 670,141 | +0.2% | 0.00% | – |
| Q1 2018 | $1,773,000 | +3.6% | 668,914 | +36.8% | 0.00% | – |
| Q4 2017 | $1,711,000 | -21.2% | 488,985 | +13.7% | 0.00% | – |
| Q3 2017 | $2,172,000 | +44.6% | 430,015 | -1.3% | 0.00% | – |
| Q2 2017 | $1,502,000 | -1.4% | 435,524 | +0.0% | 0.00% | – |
| Q1 2017 | $1,524,000 | +98.7% | 435,324 | +22.0% | 0.00% | – |
| Q4 2016 | $767,000 | -48.0% | 356,745 | -23.1% | 0.00% | – |
| Q3 2016 | $1,476,000 | +20.7% | 464,000 | +5.5% | 0.00% | – |
| Q2 2016 | $1,223,000 | +55.4% | 439,732 | +120.3% | 0.00% | – |
| Q1 2016 | $787,000 | -53.7% | 199,631 | +15.4% | 0.00% | – |
| Q4 2015 | $1,699,000 | -99.1% | 172,919 | -96.5% | 0.00% | -100.0% |
| Q3 2015 | $180,724,000 | +6155.6% | 4,897,510 | +3039.4% | 0.01% | – |
| Q2 2015 | $2,889,000 | – | 156,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|